108 related articles for article (PubMed ID: 27713244)
1. Comparison of Functional Protein Transduction Domains Using the NEMO Binding Domain Peptide.
Khaja K; Robbins P
Pharmaceuticals (Basel); 2010 Jan; 3(1):110-124. PubMed ID: 27713244
[TBL] [Abstract][Full Text] [Related]
2. Protein transduction: identification, characterization and optimization.
Tilstra J; Rehman KK; Hennon T; Plevy SE; Clemens P; Robbins PD
Biochem Soc Trans; 2007 Aug; 35(Pt 4):811-5. PubMed ID: 17635154
[TBL] [Abstract][Full Text] [Related]
3. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
4. D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.
Reay DP; Bastacky SI; Wack KE; Stolz DB; Robbins PD; Clemens PR
Mol Med; 2015 May; 21(1):442-52. PubMed ID: 26018805
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on transduction and toxicity of protein transduction domains.
Sugita T; Yoshikawa T; Mukai Y; Yamanada N; Imai S; Nagano K; Yoshida Y; Shibata H; Yoshioka Y; Nakagawa S; Kamada H; Tsunoda SI; Tsutsumi Y
Br J Pharmacol; 2008 Mar; 153(6):1143-52. PubMed ID: 18223668
[TBL] [Abstract][Full Text] [Related]
6. NEMO binding domain of IKK-2 encompasses amino acids 735-745.
Strnad J; McDonnell PA; Riexinger DJ; Mapelli C; Cheng L; Gray H; Ryseck RP; Burke JR
J Mol Recognit; 2006; 19(3):227-33. PubMed ID: 16583354
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
[TBL] [Abstract][Full Text] [Related]
8. Intercellular delivery of NF-κB inhibitor peptide utilizing small extracellular vesicles for the application of anti-inflammatory therapy.
Takenaka M; Takahashi Y; Takakura Y
J Control Release; 2020 Dec; 328():435-443. PubMed ID: 32898592
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization.
Tas SW; de Jong EC; Hajji N; May MJ; Ghosh S; Vervoordeldonk MJ; Tak PP
Eur J Immunol; 2005 Apr; 35(4):1164-74. PubMed ID: 15770694
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
12. NEMO-binding domain peptides alleviate perihematomal inflammation injury after experimental intracerebral hemorrhage.
Luo Q; Li D; Bao B; Wan X; Pan B; Tu J; Wang H; Ouyang Y; Chen Z; Yin X
Neuroscience; 2019 Jun; 409():43-57. PubMed ID: 31047976
[TBL] [Abstract][Full Text] [Related]
13. NEMO-binding domain peptide inhibition of inflammatory signal-induced NF-κB activation in vivo.
McCorkell KA; May MJ
Methods Mol Biol; 2015; 1280():505-25. PubMed ID: 25736769
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Peptide Attenuates Edema and Promotes BMP-2-Induced Bone Formation in Spine Fusion.
Glaeser JD; Salehi K; Kanim LEA; Sheyn D; NaPier Z; Behrens PH; Garcia L; Cuéllar JM; Bae HW
Tissue Eng Part A; 2018 Nov; 24(21-22):1641-1651. PubMed ID: 29766758
[TBL] [Abstract][Full Text] [Related]
15. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
16. NBD peptides protect against ischemia reperfusion after orthotopic liver transplantation in rats.
Cheng MX; Gong JP; Chen Y; Liu ZJ; Tu B; Liu CA
J Surg Res; 2012 Aug; 176(2):666-71. PubMed ID: 22381173
[TBL] [Abstract][Full Text] [Related]
17. NEMO-binding domain peptide inhibits proliferation of human melanoma cells.
Ianaro A; Tersigni M; Belardo G; Di Martino S; Napolitano M; Palmieri G; Sini M; De Maio A; Ombra M; Gentilcore G; Capone M; Ascierto M; Satriano RA; Farina B; Faraone-Mennella M; Ascierto PA; Ialenti A
Cancer Lett; 2009 Feb; 274(2):331-6. PubMed ID: 19004544
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis.
Shibata W; Maeda S; Hikiba Y; Yanai A; Ohmae T; Sakamoto K; Nakagawa H; Ogura K; Omata M
J Immunol; 2007 Sep; 179(5):2681-5. PubMed ID: 17709478
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate.
Mai JC; Shen H; Watkins SC; Cheng T; Robbins PD
J Biol Chem; 2002 Aug; 277(33):30208-18. PubMed ID: 12034749
[TBL] [Abstract][Full Text] [Related]
20. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
Kaplan IM; Wadia JS; Dowdy SF
J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
